CHINA / SOCIETY
CNBG vaccine with 86% efficacy registered in Bahrain
Published: Dec 13, 2020 04:14 PM

Photo: CNBG


Bahraini government has registered a COVID-19 vaccine developed by Chinese producer CNBG after reviewing its phase 3 clinical trial data that shows 86% efficacy rate, and 100% efficacy in preventing medium and severe symptoms.